This prospective, randomized, controlled study aims to evaluate the impact of short-term
intravenous iron dextran on postoperative recovery and the requirement for allogeneic red
blood cells (RBC) transfusion in preoperative Iron-deficiency anemia (IDA) patients receiving
orthopedic surgery, thus facilitating developing a simple and effective iron supplement
approach for patients' recovery.